Difference between revisions of "Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5 (Q9578)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 2012, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): The spectrum of JAK2-positive myeloproliferative neoplasms, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | The spectrum of JAK2-positive myeloproliferative neoplasms (English) | ||
| Property / title: The spectrum of JAK2-positive myeloproliferative neoplasms (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:58, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kiladjian JJ
0 references
2012
0 references
Hematol. Am. Soc. Hematol. Educ. Program
0 references
2012
0 references
The spectrum of JAK2-positive myeloproliferative neoplasms (English)
0 references
